Incidence of MACE is significantly increased up to 1 year following delivery in Black patients with pre-eclampsia and eclampsia.

Follicular thyroid cancer with bone involvement was associated with a significantly elevated risk for brain metastases among women.

Topline data were announced from a phase 3b trial evaluating investigational semaglutide 7.2mg in adults with obesity.

GDR, compared with other insulin resistance markers, demonstrated superior predictive value for cardiovascular outcomes such as MI.

There seems to be no association between hormone therapy (HT) and glioma risk among US women, according to a study published online.

A global commission presents a nuanced approach to defining clinical obesity as a chronic illness resulting from the effect of excess adiposity on organ and tissue function.

Both incident and recurrent heart failure hospitalization risk is associated with post-traumatic stress disorder among patients with CAD.

While sleep supplements can be beneficial, the lack of regulation means consumers are not assured of a safe and effective product.

US veterans with chronic cardiovascular conditions experiencing homelessness and unstable housing have lower outpatient care utilization.

Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes.

The FDA has accepted for review the New Drug Application for plozasiran for the treatment for familial chylomicronemia syndrome.

Risk for bleeding events is significantly affected by DOAC score in patients with atrial fibrillation who have received TAVR.